TrialLeukemia2017

Olaptesed pegol, an anti-CXCL12/SDF-1 Spiegelmer, alone and with bortezomib-dexamethasone in relapsed/refractory multiple myeloma: a Phase IIa Study.

H Ludwig et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.